| Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system MC Zimmerman, E Lazartigues, RV Sharma, RL Davisson Circulation research 95 (2), 210-216, 2004 | 534 | 2004 |
| Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system MF Doobay, LS Talman, TD Obr, X Tian, RL Davisson, E Lazartigues American Journal of Physiology-Regulatory, Integrative and Comparative …, 2007 | 494 | 2007 |
| Superoxide mediates the actions of angiotensin II in the central nervous system MC Zimmerman, E Lazartigues, JA Lang, P Sinnayah, IM Ahmad, ... Circulation research 91 (11), 1038-1045, 2002 | 461 | 2002 |
| Angiotensin‐converting enzyme 2 in the brain: properties and future directions H Xia, E Lazartigues Journal of neurochemistry 107 (6), 1482-1494, 2008 | 400 | 2008 |
| ACE2/ANG-(1–7)/Mas pathway in the brain: the axis of good P Xu, S Sriramula, E Lazartigues American Journal of Physiology-Regulatory, Integrative and Comparative …, 2011 | 367 | 2011 |
| Nicotine and the renin-angiotensin system JM Oakes, RM Fuchs, JD Gardner, E Lazartigues, X Yue American Journal of Physiology-Regulatory, Integrative and Comparative …, 2018 | 337 | 2018 |
| Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an angiotensin ii type i receptor–dependent mechanism MR Deshotels, H Xia, S Sriramula, E Lazartigues, CM Filipeanu Hypertension 64 (6), 1368-1375, 2014 | 307 | 2014 |
| The sweeter side of ACE2: physiological evidence for a role in diabetes SM Bindom, E Lazartigues Molecular and cellular endocrinology 302 (2), 193-202, 2009 | 279 | 2009 |
| Angiotensin I–converting enzyme type 2 (ACE2) gene therapy improves glycemic control in diabetic mice SM Bindom, CP Hans, H Xia, AH Boulares, E Lazartigues Diabetes 59 (10), 2540-2548, 2010 | 246 | 2010 |
| Brain-selective overexpression of human angiotensin-converting enzyme type 2 attenuates neurogenic hypertension Y Feng, H Xia, Y Cai, CM Halabi, LK Becker, RAS Santos, RC Speth, ... Circulation Research 106 (2), 373-382, 2010 | 224 | 2010 |
| ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension S Sriramula, JP Cardinale, E Lazartigues, J Francis Cardiovascular research 92 (3), 401-408, 2011 | 220 | 2011 |
| Endocrine significance of SARS-CoV-2’s reliance on ACE2 E Lazartigues, MMF Qadir, F Mauvais-Jarvis Endocrinology 161 (9), bqaa108, 2020 | 206 | 2020 |
| Requirement for Rac1-dependent NADPH oxidase in the cardiovascular and dipsogenic actions of angiotensin II in the brain MC Zimmerman, RP Dunlay, E Lazartigues, Y Zhang, RV Sharma, ... Circulation research 95 (5), 532-539, 2004 | 205 | 2004 |
| Clinical Relevance and Role of Neuronal AT1 Receptors in ADAM17-Mediated ACE2 Shedding in Neurogenic Hypertension J Xu, S Sriramula, H Xia, L Moreno-Walton, F Culicchia, O Domenig, ... Circulation research 121 (1), 43-55, 2017 | 192 | 2017 |
| Brain angiotensin-converting enzyme type 2 shedding contributes to the development of neurogenic hypertension H Xia, S Sriramula, KH Chhabra, E Lazartigues Circulation research 113 (9), 1087-1096, 2013 | 185 | 2013 |
| Angiotensin-converting enzyme 2: central regulator for cardiovascular function H Xia, E Lazartigues Current hypertension reports 12, 170-175, 2010 | 174 | 2010 |
| DOCA-salt hypertension: an update T Basting, E Lazartigues Current hypertension reports 19, 1-8, 2017 | 172 | 2017 |
| Angiotensin-converting enzyme 2 overexpression in the subfornical organ prevents the angiotensin II–mediated pressor and drinking responses and is associated with angiotensin … Y Feng, X Yue, H Xia, SM Bindom, PJ Hickman, CM Filipeanu, G Wu, ... Circulation research 102 (6), 729-736, 2008 | 159 | 2008 |
| ACE2-mediated reduction of oxidative stress in the central nervous system is associated with improvement of autonomic function H Xia, S Suda, S Bindom, Y Feng, SB Gurley, D Seth, LG Navar, ... PloS one 6 (7), e22682, 2011 | 140 | 2011 |
| Expression of ACE2 in human neurons supports the neuro-invasive potential of COVID-19 virus J Xu, E Lazartigues Cellular and Molecular Neurobiology 42 (1), 305-309, 2022 | 133 | 2022 |
Yumei Feng EarleyUniversity of Rochester Medical CenterVerified email at URMC.Rochester.edu
